Literature DB >> 34086186

MiR-141-3p and miR-200a-3p are involved in Th17 cell differentiation by negatively regulating RARB expression.

Leila Bahmani1, Masoud Baghi2,3, Maryam Peymani4, Arash Javeri5, Kamran Ghaedi6.   

Abstract

Among T helper (Th) lineages differentiated from naïve CD4+ T cells, interleukin (IL)-17-producing Th17 cells are highly correlated with the pathogenesis of autoimmune disorders. This study aimed to clarify the involvement of miR-141-3p and miR-200a-3p in Th17 cell differentiation as well as explore their potential target genes involved. For this purpose, human naïve CD4+ T cells were cultured under Th17 cell polarizing condition. The differentiation process was confirmed through measurement of IL-17 secretion using the ELISA method and assessment of Th17 cell-defining genes expression during the differentiation period. MiR-141-3p and miR-200a-3p downstream genes were identified via consensus and integration in silico approach and their expression pattern and alterations were evaluated by quantitative real-time PCR. Finally, direct interaction between both microRNAs (miRNAs) and their common predicted target sequences was approved by dual-luciferase reporter assay. Highly increased IL-17 secretion and Th17 lineage-specific genes expression confirmed Th17 cell differentiation. Our results have demonstrated that miR-141-3p and miR-200a-3p are Th17 cell-associated miRNAs and their expression level is upregulated significantly during Th17 cell induction. We have also found that retinoic acid receptor beta (RARB) gene, whose product has been reported as a negative regulator of Th17 cell generation, is a direct target of both miRNAs and its downregulation can affect the transcriptional level of JAK/STAT pathway genes. Overall, our results have identified two novel Th17 lineage-associated miRNAs and have provided evidence for the RARB-dependent mechanism of miR-141-3p and miR-200a-3p-induced Th17 cell differentiation and hence Th17-mediated autoimmunity.
© 2021. Japan Human Cell Society.

Entities:  

Keywords:  Autoimmune diseases; Human Th17 differentiation; MicroRNAs; RARB; miR-141-3p; miR-200a-3p

Mesh:

Substances:

Year:  2021        PMID: 34086186     DOI: 10.1007/s13577-021-00558-4

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  52 in total

1.  Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.

Authors:  Valentina Živković; Tatjana Cvetković; Branka Mitić; Bojana Stamenković; Sonja Stojanović; Biljana Radovanović-Dinić; Vladimir Jurišić
Journal:  Rheumatol Int       Date:  2017-11-27       Impact factor: 2.631

2.  Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Authors:  Laurie E Harrington; Robin D Hatton; Paul R Mangan; Henrietta Turner; Theresa L Murphy; Kenneth M Murphy; Casey T Weaver
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

Review 3.  Functional diversity of helper T lymphocytes.

Authors:  A K Abbas; K M Murphy; A Sher
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

Review 4.  Function of innate lymphoid cells in the immune-related disorders.

Authors:  Tanja Dzopalić; Biljana Božić-Nedeljković; Vladimir Jurišić
Journal:  Hum Cell       Date:  2019-05-11       Impact factor: 4.174

5.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

6.  Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha.

Authors:  Jason A Hall; Jennifer L Cannons; John R Grainger; Liliane M Dos Santos; Timothy W Hand; Shruti Naik; Elizabeth A Wohlfert; David B Chou; Guillaume Oldenhove; Melody Robinson; Michael E Grigg; Robin Kastenmayer; Pamela L Schwartzberg; Yasmine Belkaid
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

7.  Role of the retinoic acid receptor beta (RARbeta) during mouse development.

Authors:  N B Ghyselinck; V Dupé; A Dierich; N Messaddeq; J M Garnier; C Rochette-Egly; P Chambon; M Mark
Journal:  Int J Dev Biol       Date:  1997-06       Impact factor: 2.203

8.  Antiproliferative effect of 13-cis-retinoic acid is associated with granulocyte differentiation and decrease in cyclin B1 and Bcl-2 protein levels in G0/G1 arrested HL-60 cells.

Authors:  Ana Vuletic; Gordana Konjevic; Desanka Milanovic; Sabera Ruzdijic; Vladimir Jurisic
Journal:  Pathol Oncol Res       Date:  2010-01-19       Impact factor: 3.201

9.  IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2.

Authors:  Bing Zhu; Thomas Buttrick; Ribal Bassil; Chen Zhu; Marta Olah; Chuan Wu; Sheng Xiao; William Orent; Wassim Elyaman; Samia J Khoury
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

10.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

View more
  2 in total

1.  Saliva RNA Biomarkers of Gastrointestinal Dysfunction in Children With Autism and Neurodevelopmental Disorders: Potential Implications for Precision Medicine.

Authors:  David Q Beversdorf; Kristin Sohl; David Levitskiy; Priscilla Tennant; Robin P Goin-Kochel; Rebecca C Shaffer; Alexandra Confair; Frank A Middleton; Steven D Hicks
Journal:  Front Psychiatry       Date:  2022-01-20       Impact factor: 4.157

Review 2.  Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease.

Authors:  Reza Yarani; Ali Shojaeian; Oana Palasca; Nadezhda T Doncheva; Lars Juhl Jensen; Jan Gorodkin; Flemming Pociot
Journal:  Front Immunol       Date:  2022-06-06       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.